Clinical Trials Directory

Trials / Unknown

UnknownNCT04622397

Local Subfascial and Intramuscular Tranexamic Acid Administration in Pediatric Patient Undergoing Scoliosis Surgery, Double Blind Randomized Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

We hypothesized that local administration of tranexamic acid will minimize blood loss and blood product administration in pediatric patient undergoing scoliosis surgery

Detailed description

Spine surgery in paediatrics is frequently associated with substantial blood loss. Blood product adminestration in children has many complications that are not fully known. There are many modalities currently available to reduce blood loss in pediatric patients. Tranexamic acid is tissue plasminogen activator inhibitor that reduce perioperative blood loss. To date, no studies have investigated effect of local administration of tranexamic acid in pediatric population undergoing scoliosis surgery.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic acid injectionLocal subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision
DRUGSalineLocal subfascial and intramuscular infiltration will be performed by surgeon at levels of fixation prior to skine incision

Timeline

Start date
2021-01-10
Primary completion
2021-11-29
Completion
2021-12-29
First posted
2020-11-10
Last updated
2020-11-10

Source: ClinicalTrials.gov record NCT04622397. Inclusion in this directory is not an endorsement.